DAX24.431 +0,2%Est505.634 -0,3%MSCI World4.348 +0,3%Top 10 Crypto17,24 +1,4%Nas22.876 +0,4%Bitcoin106.468 +1,0%Euro1,1713 -0,1%Öl65,16 +1,2%Gold3.957 +1,8%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
DroneShield A2DMAA Plug Power A1JA81 Rheinmetall 703000 AMD (Advanced Micro Devices) 863186 NVIDIA 918422 RENK RENK73 Tesla A1CX3T HENSOLDT HAG000 Siemens Energy ENER6Y Novo Nordisk A3EU6F Palantir A2QA4J BASF BASF11 NEL ASA A0B733 D-Wave Quantum A3DSV9 Lufthansa 823212
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
'Shutdown' bleibt bestehen: DAX fester -- US-Börsen uneins -- AMD und OpenAI mit Milliardendeal -- Tesla, Alibaba, BYD, D-Wave, DroneShield, Plug Power, Airbus, Rheinmetall & Co. im Fokus
Top News
JP Morgan Chase & Co.: GEA-Aktie erhält Underweight JP Morgan Chase & Co.: GEA-Aktie erhält Underweight
18 Uhr live mit Ingmar Königshofen: Systematisch Trading-Chancen identifizieren - so geht es an den Märkten weiter! 18 Uhr live mit Ingmar Königshofen: Systematisch Trading-Chancen identifizieren - so geht es an den Märkten weiter!
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

BioXcel Therapeutics Aktie

Kaufen
Verkaufen
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2JF20

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS09075P1057

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolBTAI

BioXcel Therapeutics Aktien News

DatumMeistgelesen
BenzingaBioXcel Therapeutics (BTAI) Stock Is Surging Monday: What's Going On?
ZacksBioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates
BenzingaBioXcel Therapeutics (BTAI) Stock Is Extremely Volatile Today: What's Going On?
ZacksBioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates
ZacksBioXcel Therapeutics, Inc. (BTAI) Reports Q4 Loss, Tops Revenue Estimates
ZacksBioXcel Therapeutics, Inc. (BTAI) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
ZacksBioXcel Therapeutics (BTAI) Moves to Buy: Rationale Behind the Upgrade
ZacksBioXcel Therapeutics, Inc. (BTAI) Reports Q3 Loss, Lags Revenue Estimates
ZacksWill BioXcel Therapeutics, Inc. (BTAI) Report Negative Q3 Earnings? What You Should Know
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioXcel Therapeutics, Inc. - BTAI
PR NewswireSHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 5, 2023 in the Class Action Filed on Behalf of BioXcel Therapeutics, Inc.(BTAI) Shareholders
PR NewswireBIOXCEL INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioXcel To Contact Him Directly To Discuss Their Options
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioXcel Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 5, 2023 - (NASDAQ: BTAI)
PR NewswireBIOXCEL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Agains...
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioXcel Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 5, 2023 - (NASDAQ: BTAI)
PR NewswireBIOXCEL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against BioXcel Therapeutics, Inc. - BTAI
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioXcel Therapeutics, Inc. - BTAI
PR NewswireBTAI LAWSUIT ALERT: Levi & Korsinsky Notifies BioXcel Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
PR NewswireBioXcel Therapeutics, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of BioXcel Therapeutics, Inc. of Deadline in Securities Fraud Class Action Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioXcel Therapeutics, Inc. - BTAI
PR NewswireCLASS ACTION ALERT: The Law Offices of Vincent Wong Remind BioXcel Investors of a Lead Plaintiff Deadline of September 5, 2023
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioXcel Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 5, 2023 - (NASDAQ: BTAI)
PR NewswireBTAI Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against BioXcel Therapeutics, Inc. (BTAI) and Encourages In...
PR NewswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioXcel Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 5, 2023 - (NASDAQ: BTAI)
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioXcel Therapeutics, Inc. - BTAI

BioXcel Therapeutics News

BioXcel Therapeutics News: auf dieser Seite finden Sie alle BioXcel Therapeutics News und Nachrichten zur BioXcel Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch BioXcel Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um BioXcel Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.